ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Chai Discovery, an OpenAI-backed AI biology startup valued at $4 billion, signed four major AI tools deals with pharma companies at the JPM conference in January. Cofounder Matt McPartlon and product lead Neil Patil discussed the deals in a podcast.
Tap to vote and see what everyone thinks.
Summary by ByteBrief